Cipro, Nolvadex Settlements No “Barr” To Generic Entrants, Courts Say
Executive Summary
Barr's agreements settling ciprofloxacin and tamoxifen patent litigation with Bayer and AstraZeneca did not prevent other generic companies from attempting to enter the market, two courts recently concluded